← Back to Patent Explorer
US4162307A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for anaesthesia by use of a pentapeptide

Assignee: SmithKline Beecham Corp
•
Filing: 1978-07-21
•
Granted: 1979-07-24
•
Expires: 1998-07-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for the induction and/or maintenance of anaesthesia or of neuroleptanalgesia in a mammal comprising the administration to the mammal of an anaesthetic-effective or of a neuroleptanalgesic-effective, non-toxic amount of a peptide of formula H.Tyr.D-Ala.Gly.Phe.D-Leu.NHEt or a pharmacologically and pharmaceutically acceptable acid addition salt thereof.

Inventors

  • 👤 Samuel Wilkinson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 09:21
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/665; C07K14/675; C07K14/6755; C07K14/70; C07K14/702

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 39 words
A method for the induction and/or maintenance of anaesthesia in a mammal, comprising the administration to the mammal of an anaesthetic-effective, non-toxic amount of a peptide of formula H.Tyr.D-Ala.Gly.Phe.D-Leu.NHEt or a pharmacologically and pharmaceutically acceptable acid addition salt thereof.
Claim 2
Independent Claim 39 words
A method for the induction and/or maintenance of anaesthesia in a mammal, comprising the administration to the mammal of an anaesthetic-effective, non-toxic amount of a peptide of formula H.Tyr.D-Ala.Gly.Phe.D-Leu.NHEt or a pharmacologically and pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 32 words
A method according to claim 1 wherein a pharmaceutical formulation comprising the peptide or acid addition salt thereof together with a pharmaceutically and pharmacologically acceptable carrier therefor is administered to the mammal.
Claim 4
Dependent Claim 39 words
A method according to claim 1 wherein the peptide or acid addition salt thereof is administered at a dosage in the range of from 0.0025 μg to 40 mg per kilogramme bodyweight of the mammal, calculated as the base.
Claim 5
Dependent Claim 11 words
A method according to claim 1 wherein the mammal is man.

References Cited (Backward Citations)

US4123523A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-07-23 1983-01-22 1983-07-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-07-23 1987-01-22 1987-07-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-07-23 1991-01-22 1991-07-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag